Director's blog
院長日記

The first patient of human-derived mesenchymal stem cell culture supernatant (exosome) therapy

武本 重毅

Aging treatment has been working in our clinic since last year.

Thanks to all of you because it became popular today.

NMN (nicotinamide mononucleotide) drip therapy started in April last year.

And in June, I started hydrogen gas inhalation therapy.

The number of users of each therapy is increasing.

 

Moreover

as the third arrow of aging treatment,

we started human-derived mesenchymal stem cell culture supernatant (exosomes) therapy at our clinic from this week.

 

This therapy is aimed at customer’s own

anti-aging

as well as

improvement of decline due to aging, etc.

One way to achieve these goals is

the culture supernatant (excluding cells), obtained by culturing human-derived mesenchymal stem cells, is administered.

 

The stem cell culture supernatant used in our clinic obtained by culturing human-derived mesenchymal stem cells (those whose safety has been confirmed by testing for infectious diseases).

 

It contains cytokines (growth factors) and abundant exosomes (a type of extracellular endoplasmic reticulum), which have been attracting attention recently.

The expected effect is appeared by the work of cytokines and exosomes contained in stem cell culture supernatant as below:

 

By subcutaneous injection

Improvement of skin firmness and wrinkles

Whitening effect

Hair growth effect

Decrease in gray hair, etc.

 

On the other hand,

By intravenous drip

Targets of this treatment like according to stem cell therapy as follow:

Cranial nerve

Neurodegeneration

Cardiology

Respiratory

Digestive organ

Metabolism

Immunity

and

Malignant tumor.

 

There are a wide range of reports, including the effects of this aging treatment.

Author:

武本 重毅

聚楽内科クリニックの院長、医学博士。